Upcoming Allied Market Research
Mucormycosis Market

Mucormycosis Market

by Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), by Fungi Type (Dermatophytes, Yeasts, Molds, Others), by  Route of Administration (Oral, Intravenous, Topical) and by End User (Hospitals, Homecare, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12066
Pages: NA
Jul 2023 | 1093 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Mucormycosis Market

Request Now !

Mucormycosis, also known as zygomycosis, is a serious but rare fungal infection caused by a group of molds called mucormycetes. Furthermore, by inhaling fungal spores from the air can affect the lungs and sinuses. In addition, the fungus invades the skin through wounds such as cuts, scrape, burn, or other types of skin trauma. The fungal infection may affect anyone, but they are most common in people with weakened immune systems and can occur in nearly any part of the body. In addition, cases of mucormycosis have increased in COVID-19 patients who have received treatment. Steroid medicines are commonly used to manage the disease condition in these patients, and while they are effective in treating corona, they also weaken the immune system and raise blood sugar levels, making patients more susceptible to mucormycosis. Moreover, risk factors for developing mucormycosis include cancer, uncontrolled diabetes, neutropenia, and organ transplant. Mucormycosis symptoms vary depending on the extent of tissue involvement, but common symptoms include pain, fever, sinus pain, and organ cellulitis. The prognosis of mucormycosis is usually poor. It depends on various factors such as the patient's overall health & ability to respond to treatments, the speed of diagnosis, and the treatment provided. However, antifungal medications, such as amphotericin B, posaconazole, or isavuconazole are used to treat these infections.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected witness a significant growth in the future owing to the demand for vaccine and treatment

drugs for COVID-19. This, in turn, is expected to have a significant impact on the mucormycosis market.

Top Impacting Factors

Increase in prevalence of fungal infections and rise in incidence of immunological diseases drive the growth of the mucormycosis market.

In addition, the exponential increase in cases of COVID-19 associated with mucormycosis in certain parts of the world is expected to be the major factor for the growth of the market during the forecast period.

Furthermore, increase in organ and bone marrow transplantation along with rise in hematological cancer cases and surge in diabetic patients since these have a weak immune system propel growth of the market.

The pandemic has an increased risk of mucormycosis, as COVID-19 patients are immune-compromised by the use of certain drugs used in viral treatment, which will further boost market growth.

Rise in use of steroids and other antiviral drugs will significantly impact the immune system of the patient. The steroid treatment increases the blood glucose levels in corona patients, which makes them more susceptible to mucormycosis, thereby supporting the growth of the market.

However, side effects of the drugs and presence of misbranded drugs hinder the growth of the market.

Market Trends

New Product Launches to Flourish the Market

In 2020,Pfizer Inc. in association with its partner Basilea Pharmaceutica Ltd., launched Cresemba (isavuconazole). The drug is used in mucormycosis and invasive aspergillosis.

In May 2021, TLC Pharma, a clinical-stage specialty pharmaceutical company, received approval for the New Drug Application (NDA) for Amphotericin B liposome injection (AmphoTLC), form the Central Drugs Standard Control Organization (CDSCO) of India. The drug can be used in the treatment of fungal infections including mucormycosis infections.

In June 2021, Celon Laboratories launched an alternative drug, Amphotericin B Emulsion for the treatment of mucormycosis.

Increase in Incidences of Mucormycosis

Rise in cases of mucormycosis in COVID-19 affected countries, especially in India notably contributes toward the market growth. In India, there is an enormous increase in fungal infection, and in few hospitals in urban areas, five to ten people are coming for mucormycosis treatment.

In the U.S. alone, more than 33 million people are affected by the disease till now. India is facing the worst second wave where 4, 00,000 cases are detected every day, which is the highest number of cases for any country from the beginning of the pandemic. The increasing cases of COVID-19 will significantly increase the number of mucormycosis cases across the globe which will further influence the market growth.

Key Benefits of the Report

  • This study presents the analytical depiction of the mucormycosis market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the mucormycosis market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Mucormycosis Market Report

  • Which are the leading players active in the mucormycosis market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is mucormycosis market?
  • What is mucormycosis market prediction in the future?
  • Who are the leading global players in the mucormycosis market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the mucormycosis market report?                                                                                                                                                                                                                        

Mucormycosis Market Report Highlights

Aspects Details
By Drug Class
  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others
By Fungi Type
  • Dermatophytes
  • Yeasts
  • Molds
  • Others
By  Route of Administration
  • Oral
  • Intravenous
  • Topical
By End User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Zydus Cadila, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc., Sanofi, Lupin, Cipla Inc., Novartis AG, Pfizer Inc., Aurobindo Pharma

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.


Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Mucormycosis Market

Start reading.
This Report and over 53,643+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers